Jinxin Fertility Group (OTCMKTS:JXFGF – Get Free Report) is expected to be posting its results before the market opens on Thursday, March 26th. Analysts expect Jinxin Fertility Group to post earnings of $0.0043 per share and revenue of $190.1590 million for the quarter.
Jinxin Fertility Group Stock Performance
OTCMKTS JXFGF opened at $0.29 on Tuesday. Jinxin Fertility Group has a twelve month low of $0.28 and a twelve month high of $0.49. The stock has a fifty day simple moving average of $0.29 and a 200 day simple moving average of $0.29.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group lowered Jinxin Fertility Group to a “sell” rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.
About Jinxin Fertility Group
Jinxin Fertility Group (OTCMKTS:JXFGF) is a Cayman Islands–incorporated company that provides a full spectrum of assisted reproductive and fertility services through its network of clinics and laboratory facilities in mainland China. The company offers in vitro fertilization (IVF), intrauterine insemination (IUI), egg and sperm cryopreservation, pre-implantation genetic testing and counseling, and related reproductive health services designed to support couples and individuals seeking to build families.
Since its founding in 2014, Jinxin Fertility Group has expanded its presence into multiple major cities, partnering with local hospitals and healthcare institutions to deliver standardized clinical protocols and advanced laboratory capabilities.
Read More
Receive News & Ratings for Jinxin Fertility Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jinxin Fertility Group and related companies with MarketBeat.com's FREE daily email newsletter.
